Five Trends Set to Shape the Future of Obesity Care: Ajanta Pharma
The future of obesity care will involve multidisciplinary collaboration between physicians, dieticians, fitness professionals and patient support teams, says Ajanta Pharma.
The future of obesity care will involve multidisciplinary collaboration between physicians, dieticians, fitness professionals and patient support teams, says Ajanta Pharma.
The partnership between Suzhou Ribo Life Science and Madrigal Pharmaceuticals focuses on developing RNA-based therapeutics for metabolic dysfunction-associated steatohepatitis (MASH).
Unlike many existing treatments for fatty liver disease that mainly focus on weight loss, this new experimental drug targets the disease process itself.